Selection of an ASIC1a-blocking Combinatorial Antibody That Protects Cells from Ischemic Death.
Min Qiang,Xue Dong,Zhao Zha,Xiao-Kun Zuo,Xing-Lei Song,Lixia Zhao,Chao Yuan,Chen Huang,Pingdong Tao,Qin Hu,Wei-Guang Li,Wanhui Hu,Jie Li,Yan Nie,Damiano Buratto,Francesco Zonta,Peixiang Ma,Zheng Yu,Lili Liu,Yi Zhang,Bei Yang,Jia Xie,Tian-Le Xu,Zhihu Qu,Guang Yang,Richard A. Lerner
DOI: https://doi.org/10.1073/pnas.1807233115
2018-01-01
Abstract:Acid-sensing ion channels (ASICs) have emerged as important, albeit challenging therapeutic targets for pain, stroke, etc. One approach to developing therapeutic agents could involve the generation of functional antibodies against these channels. To select such antibodies, we used channels assembled in nanodiscs, such that the target ASIC1a has a configuration as close as possible to its natural state in the plasma membrane. This methodology allowed selection of functional antibodies that inhibit acid-induced opening of the channel in a dose-dependent way. In addition to regulation of pH, these antibodies block the transport of cations, including calcium, thereby preventing acid-induced cell death in vitro and in vivo. As proof of concept for the use of these antibodies to modulate ion channels in vivo, we showed that they potently protect brain cells from death after an ischemic stroke. Thus, the methodology described here should be general, thereby allowing selection of antibodies to other important ASICs, such as those involved in pain, neurodegeneration, and other conditions.